Home Page

Company Profile

SierraNeuro

SierraNeuro is a biopharmaceutical company focused on the development and commercialization of centrally administered small molecule therapeutics for the treatment of severe CNS diseases refractory to oral medications. Many currently available effective oral therapies can be highly toxic to body systems involved in the metabolism and excretion of these agents. This toxicity greatly limits a physician's ability to utilize agents that could otherwise be of great benefit. In addition, patients are often unable to consistently take oral medications because of their disease or related circumstances. Sierra has addressed these problems through a proprietary development process that reformulates highly effective but systemically toxic oral medications, enabling placement into an implantable drug delivery pump for direct administration in the fluid around the brain. This innovative delivery approach will expand treatment options in refractory CNS diseases including Epilepsy, Schizophrenia, Bipolar Disorder, Anxiety Disorders and Major Depression. Implantable drug delivery pumps for use in the nervous system are well established in the medical community, in terms of safety and effective administration.